 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 February 1996 | Volume 124 Issue 3 | Pages 292-298
Objectives: To determine how often aspirin was prescribed as a discharge medication to eligible patients 65 years of age and older who were hospitalized with an acute myocardial infarction; to identify patient characteristics associated with the decision to use aspirin; and to evaluate the association between prescription of aspirin at discharge and 6-month survival.
Design: Observational study.
Setting: All 352 nongovernment, acute care hospitals in Alabama, Connecticut, Iowa, and Wisconsin.
Patients: 5490 consecutive Medicare beneficiaries who survived an acute myocardial infarction, were hospitalized between June 1992 and February 1993, and did not have a contraindication to aspirin.
Measurements: Medical charts were reviewed to obtain information on the prescription of aspirin at discharge, contraindications, patient demographic characteristics, and clinical factors.
Results: 4149 patients (76%) were prescribed aspirin at hospital discharge. In a multivariable analysis, an increased prescribed use of aspirin at discharge was correlated with several indicators of better overall health status (better left ventricular ejection fraction, absence of diabetes, shorter length of hospital stay, higher albumin level, and discharge to the patient's home). The prescribed use of aspirin at discharge was also associated with several specific patterns of care, including the use of cardiac procedures, ß-blocker therapy at discharge, and aspirin during the hospitalization. The prescribed use of aspirin at discharge was associated with a lower mortality rate 6 months after discharge compared with no prescribed aspirin (odds ratio, 0.77; 95% CI, 0.61 to 0.98), even after adjustment for baseline differences in demographic, clinical, and treatment characteristics between the two groups.
Conclusions: Aspirin was not prescribed at discharge to 24% of elderly patients who were hospitalized with an acute myocardial infarction and did not have a contraindication to aspirin. Several patient characteristics were associated with a higher risk for not being prescribed aspirin. Increasing the prescription of aspirin for these patients may provide an excellent opportunity to improve their care.
Author and Article Information
From Yale School of Medicine, New Haven, Connecticut; the Connecticut Peer Review Organization, Middletown, Connecticut; University of Connecticut Medical School, Farmington, Connecticut; and the Health Care Financing Administration, Baltimore, Maryland.
ARTICLE
Aspirin for Secondary Prevention after Acute Myocardial Infarction in the Elderly: Prescribed Use and Outcomes
Disclaimer: This paper does not necessarily represent the official position of the Health Care Financing Administration.
Acknowledgments: The authors thank the members of the Peer Review Organizations from Alabama, Connecticut, Iowa, and Wisconsin and all the other persons, hospitals, and organizations who contributed to the development and implementation of the Cooperative Cardiovascular Project; and Dr. Richard Krumholz for his constructive comments on the manuscript.
Grant Support: In part by the Patrick and Catherine Weldon Donaghue Medical Research Foundation.
Requests for Reprints: Harlan M. Krumholz, MD, Cardiovascular Section, Yale School of Medicine, 333 Cedar Street, PO Box 208017, New Haven, CT 06520-8017.
Current Author Addresses: Dr. Krumholz: Cardiovascular Section, Yale School of Medicine, 333 Cedar Street, PO Box 208017, New Haven, CT 06520-8017.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  H. M. Krumholz Outcomes Research: Generating Evidence for Best Practice and Policies Circulation, July 15, 2008; 118(3): 309 - 318. [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Krumholz, E. H. Bradley, B. K. Nallamothu, H. H. Ting, W. B. Batchelor, E. Kline-Rogers, A. F. Stern, J. R. Byrd, and J. E. Brush Jr A Campaign to Improve the Timeliness of Primary Percutaneous Coronary Intervention: Door-to-Balloon: An Alliance for Quality J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 97 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Krumholz Guideline Recommendations and Results: The Importance of the Linkage Ann Intern Med, September 4, 2007; 147(5): 342 - 343. [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Aronow Use of Antiplatelet Drugs in Secondary Prevention in Older Persons With Atherothrombotic Disease J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2007; 62(5): 518 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Shah, J. E. Hux, and P. C. Austin Diabetes Is Not Treated as a Coronary Artery Disease Risk Equivalent Diabetes Care, February 1, 2007; 30(2): 381 - 383. [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Masoudi, P. Wolfe, E. P. Havranek, S. S. Rathore, J. M. Foody, and H. M. Krumholz Aspirin Use in Older Patients With Heart Failure and Coronary Artery Disease: National Prescription Patterns and Relationship With Outcomes J. Am. Coll. Cardiol., September 20, 2005; 46(6): 955 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Aronow Management of the Elderly Person After Myocardial Infarction J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2004; 59(11): 1173 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Havranek, P. Wolfe, F. A. Masoudi, S. S. Rathore, H. M. Krumholz, and D. L. Ordin Provider and Hospital Characteristics Associated With Geographic Variation in the Evaluation and Management of Elderly Patients With Heart Failure Arch Intern Med, June 14, 2004; 164(11): 1186 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Ko, M. Mamdani, and D. A. Alter Lipid-Lowering Therapy With Statins in High-Risk Elderly Patients: The Treatment-Risk Paradox JAMA, April 21, 2004; 291(15): 1864 - 1870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A Dornbrook-Lavender, M. T Roth, and J. A Pieper Secondary Prevention of Coronary Heart Disease in the Elderly Ann. Pharmacother., December 1, 2003; 37(12): 1867 - 1876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. SCOTT, K. HEATH, C. HARPER, and A. CLOUGH An Australian comparison of specialist care of acute myocardial infarction Int. J. Qual. Health Care, March 1, 2003; 15(2): 155 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Freedman, R. C. Becker, J. E. Adams, S. Borzak, R. L. Jesse, L. K. Newby, P. O'Gara, J. C. Pezzullo, R. Kerber, B. Coleman, et al. Medication Errors in Acute Cardiac Care: An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Nursing, and Council on Stroke Circulation, November 12, 2002; 106(20): 2623 - 2629. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chyun, V. Vaccarino, J. Murillo, L. H. Young, and H. M. Krumholz Cardiac Outcomes After Myocardial Infarction in Elderly Patients With Diabetes Mellitus Am. J. Crit. Care., November 1, 2002; 11(6): 504 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Desmond, J. T. Moroney, M. Sano, and Y. Stern Mortality in patients with dementia after ischemic stroke Neurology, August 27, 2002; 59(4): 537 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Gaspoz, P. G. Coxson, P. A. Goldman, L. W. Williams, K. M. Kuntz, M.G. M. Hunink, and L. Goldman Cost Effectiveness of Aspirin, Clopidogrel, or Both for Secondary Prevention of Coronary Heart Disease N. Engl. J. Med., June 6, 2002; 346(23): 1800 - 1806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ghosh, V. Ziesmer, and W. S. Aronow Underutilization of Aspirin, Beta Blockers, Angiotensin-Converting Enzyme Inhibitors, and Lipid-Lowering Drugs and Overutilization of Calcium Channel Blockers in Older Persons With Coronary Artery Disease in an Academic Nursing Home J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2002; 57(6): M398 - 400. [Abstract] [Full Text]
|
|
|
|
|
|
S. B. Soumerai, T. J. McLaughlin, D. Ross-Degnan, C. L. Christiansen, and J. H. Gurwitz Effectiveness of Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly: Cause for Concern in the Old-Old Arch Intern Med, March 11, 2002; 162(5): 561 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Brown, T. E. Delea, G. A. Nichols, J. Edelsberg, P. J. Elmer, and G. Oster Use of Oral Antithrombotic Agents Among Health Maintenance Organization Members With Atherosclerotic Cardiovascular Disease Arch Intern Med, January 28, 2002; 162(2): 193 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Marchioli, F Avanzini, F Barzi, C Chieffo, A Di Castelnuovo, M.G Franzosi, E Geraci, A.P Maggioni, R.M Marfisi, N Mininni, et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart Eur. Heart J., November 2, 2001; 22(22): 2085 - 2103. [Abstract] [PDF]
|
|
|
|
 |
|
 B. G. Druss, W. D. Bradford, R. A. Rosenheck, M. J. Radford, and H. M. Krumholz Quality of Medical Care and Excess Mortality in Older Patients With Mental Disorders Arch Gen Psychiatry, June 1, 2001; 58(6): 565 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Krumholz, Y.-T. Chen, Y. Wang, and M. J. Radford Aspirin and Angiotensin-Converting Enzyme Inhibitors Among Elderly Survivors of Hospitalization for an Acute Myocardial Infarction Arch Intern Med, February 26, 2001; 161(4): 538 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Straus and F. A. McAlister Evidence-based medicine: a commentary on common criticisms Can. Med. Assoc. J., October 1, 2000; 163(7): 837 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Gan, S. K. Beaver, P. M. Houck, R. F. MacLehose, H. W. Lawson, and L. Chan Treatment of Acute Myocardial Infarction and 30-Day Mortality among Women and Men N. Engl. J. Med., July 6, 2000; 343(1): 8 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Mehta, T. J. Ruane, P. A. McCargar, K. A. Eagle, and E. J. Stalhandske The Treatment of Elderly Diabetic Patients With Acute Myocardial Infarction: Insight From Michigan's Cooperative Cardiovascular Project Arch Intern Med, May 8, 2000; 160(9): 1301 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Measuring and Improving Quality of Care : A Report From the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke Stroke, April 1, 2000; 31(4): 1002 - 1012. [Full Text] [PDF]
|
|
|
|
|
|
Measuring and Improving Quality of Care : A Report From the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke Circulation, March 28, 2000; 101(12): 1483 - 1493. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Stafford Aspirin Use Is Low Among United States Outpatients With Coronary Artery Disease Circulation, March 14, 2000; 101(10): 1097 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. N. Kernan, C. M. Viscoli, L. M. Brass, R. W. Makuch, P. M. Sarrel, and R. I. Horwitz Blood Pressure Exceeding National Guidelines Among Women After Stroke Stroke, February 1, 2000; 31(2): 415 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hillen, R. Dundas, E. Lawrence, J. A. Stewart, A. G. Rudd, and C. D. A. Wolfe Antithrombotic and Antihypertensive Management 3 Months After Ischemic Stroke : A Prospective Study in an Inner City Population Stroke, February 1, 2000; 31(2): 469 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. McCormick, J. H. Gurwitz, D. Lessard, J. Yarzebski, J. M. Gore, and R. J. Goldberg Use of Aspirin, {beta}-Blockers, and Lipid-Lowering Medications Before Recurrent Acute Myocardial Infarction: Missed Opportunities for Prevention? Arch Intern Med, March 22, 1999; 159(6): 561 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Hood, C. Wark, P. A. Burgess, D. Nicewander, and M. W. Scott Screening for Helicobacter pylori and Nonsteroidal Anti-inflammatory Drug Use in Medicare Patients Hospitalized With Peptic Ulcer Disease Arch Intern Med, January 25, 1999; 159(2): 149 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Marciniak, L. Mosedale, and E. F. Ellerbeck Quality Improvement at the National Level: Lessons From the Cooperative Cardiovascular Project Eval Health Prof, December 1, 1998; 21(4): 525 - 536. [Abstract] [PDF]
|
|
|
|
|
|
L. M. Brass, H. M. Krumholz, J. D. Scinto, D. Mathur, and M. Radford Warfarin Use Following Ischemic Stroke Among Medicare Patients With Atrial Fibrillation Arch Intern Med, October 26, 1998; 158(19): 2093 - 2100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Donohoe Comparing Generalist and Specialty Care: Discrepancies, Deficiencies, and Excesses Arch Intern Med, August 10, 1998; 158(15): 1596 - 1608. [Abstract] [Full Text]
|
|
|
|
|
|
D. M. Klubert, C. Courtright, E. D. Huff, and L. I. Iezzoni Risk Adjustment, Quality Assessment, and Process of Care JAMA, March 25, 1998; 279(12): 910 - 911. [Full Text] [PDF]
|
|
|
|
|
|
L. M. Brass, H. M. Krumholz, J. M. Scinto, and M. Radford Warfarin Use Among Patients With Atrial Fibrillation Stroke, December 1, 1997; 28(12): 2382 - 2389. [Abstract] [Full Text]
|
|
|
|
 |
|
 . . . Aspirin . . Journal Watch Cardiology, March 1, 1996; 1996(301): 2 - 2. [Full Text]
|
|
|
|
 |
|
 ASPIRIN COULD BENEFIT MORE MI SURVIVORS Journal Watch (General), February 27, 1996; 1996(227): 3 - 3. [Full Text]
|
|
Article
